Frank C. Arnett, MD ⁎, a, b, 1
Supported by the George S. Bruce, Jr. Professorship in Arthritis and Other Rheumatic Diseases (FCA) and NIH grants RO1 AR31133, RO1 AR32214 and PO1 AI21568 (MR).
, Morris Reichlin, MD c, 1
Supported by the George S. Bruce, Jr. Professorship in Arthritis and Other Rheumatic Diseases (FCA) and NIH grants RO1 AR31133, RO1 AR32214 and PO1 AI21568 (MR).
a Division of Rheumatology and Clinical Immunogenetics, Department of Internal Medicine, The University of Texas-Houston Health Science Center, Houston, Texas USA.
b Department of Pathology and Laboratory Medicine, The University of Texas-Houston Health Science Center, Houston, Texas USA.
c the Rheumatology Section, University of Oklahoma Medical Center, Arthritis and Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.